Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
AM Best has assigned a 'bbb' (Good) rating to Humana Inc.'s new senior unsecured notes: $750 million at 5.5% due 2035 and $500 million at 6.0% due 2055. The proceeds will be used for general corporate purposes, including repayment of $600 million in existing debt due April 2025 and approximately $885 million in commercial paper.
The issuance will temporarily increase financial leverage from 42% to approximately 45%, above Humana's long-term target of 40%. While EBIT interest coverage remains solid at 5-8 times, it has declined from previous double-digit levels due to increased Medicare Advantage utilization and reimbursement changes in 2023-2024.
Humana maintains strong liquidity with $3 billion in operating cash flows and $1.5 billion in subsidiary dividends for 2024. The company's financial position is supported by $4.75 billion in credit lines and a $4 billion commercial paper program.
Humana (NYSE: HUM) has announced pricing for a $1.25 billion senior notes offering, comprising $750 million of 5.550% notes due 2035 and $500 million of 6.000% notes due 2055. The offering is expected to close on March 5, 2025.
The company anticipates net proceeds of approximately $1.231 billion after deducting underwriters' discounts and offering expenses. These funds will be primarily used to repay Humana's 4.500% Senior Notes due in April 2025, with the remainder allocated for general corporate purposes, including potential repayment of existing debt and commercial paper borrowings.
The offering is being managed by joint book-running managers including Barclays Capital, BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and U.S. Bancorp Investments.
Humana (NYSE: HUM) has announced a new value-based care partnership with Thyme Care to enhance cancer care support for eligible Medicare Advantage members. The collaboration aims to provide comprehensive oncology services through 24/7 virtual care navigation and data-driven insights.
The program is now available to eligible Humana Medicare Advantage members in seven states: Michigan, New York, Illinois, Indiana, Tennessee, Pennsylvania, and New Jersey. Key services include:
- 24/7 virtual care navigation with dedicated oncology care teams
- Community support for resources like financial assistance and transportation
- Coordinated care between oncologists, primary care physicians, and specialists
The initiative focuses on reducing care gaps, minimizing unnecessary expenses, and providing comprehensive support for cancer patients while managing treatment complexities and costs.
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), has announced a $250,000 donation to support disaster recovery efforts in Eastern Kentucky following catastrophic flooding and winter snowstorm activity. The donation will be split between two organizations: $150,000 to the Foundation for Appalachian Kentucky and $100,000 to the Team Kentucky Storm Relief Fund.
The devastating floods have resulted in at least 14 deaths and left many residents in Pike and Madison Counties displaced without access to clean drinking water. The funds will provide immediate support for basic needs including food, shelter, water, and medical care, while also addressing long-term recovery needs of affected communities.
Governor Beshear acknowledged the donation, praising the Humana Foundation's continued partnership with Team Kentucky. Tiffany Benjamin, CEO of the Humana Foundation, emphasized their commitment to supporting diverse and underserved communities during crisis situations.
Humana (NYSE: HUM) has announced its Board of Directors' declaration of a quarterly cash dividend of $0.885 per share. The dividend will be payable on April 25, 2025, to stockholders of record as of the close of business on March 28, 2025.
The company operates through Humana insurance services and CenterWell health care services, focusing on providing healthcare solutions for people with Medicare, Medicaid, families, individuals, military service personnel, and communities. Their mission centers on making healthcare access easier and improving quality of life for their customers.
CenterWell Senior Primary Care and Conviva, Humana's primary care brands, announced expansion plans for 2025, targeting 20-30 new centers across 10 states and four new metro areas. The expansion includes new locations in Augusta and Savannah (Georgia), the Triad Region (North Carolina), and Wichita (Kansas).
As the nation's largest senior primary care provider, the organization currently serves approximately 390,000 seniors across more than 340 centers as of December 31, 2024. The expansion includes completing the opening of 11 Walmart co-located centers by mid-2025.
The companies operate under a value-based care model, with physicians spending up to 50% more time with patients compared to typical providers. A Harvard University and Humana Health Research study confirmed their model offers better access to primary care compared to other organizations.
Humana and Monogram Health have announced a significant expansion of their comprehensive kidney care program. The expansion extends in-home treatment access for Medicare Advantage members with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) across Alabama, Louisiana, Mississippi, Tennessee, and now Georgia.
The collaboration focuses on value-based care, enabling earlier interventions and reaching new patients, particularly in Georgia. The program provides evidence-based nephrology and multispecialty care in patients' homes, addressing not only kidney disease but also underlying conditions like hypertension, diabetes, and metabolic disorders.
This initiative is particularly significant as chronic kidney disease affects approximately 37 million Americans, with nearly 15% of the Medicare-aged population in Alabama, Tennessee, and Louisiana having CKD - among the highest prevalence rates nationwide. The program aims to address the notable gap in specialized care access, as most CKD patients have never consulted a nephrologist.
Humana (HUM) reported a fourth quarter 2024 net loss of $5.76 per share on a GAAP basis and an adjusted net loss of $2.16 per share. For full-year 2024, the company reported earnings of $9.98 per share (GAAP) and $16.21 (adjusted).
The company's Insurance segment Adjusted benefit ratio was 91.9% in Q4 2024, including a 20-basis point increase related to Star Ratings investments. For 2025, Humana expects GAAP EPS of approximately $15.88 and adjusted EPS of approximately $16.25.
Notably, Humana anticipates an individual Medicare Advantage membership decline of approximately 550,000 members (10%) from 2024, due partly to exiting certain unprofitable plans and counties. The company is advancing its Medicaid and CenterWell strategies, which are expected to drive increased earnings contribution over the mid and longer term.
Humana Inc. (NYSE: HUM) released its annual Value-Based Care Report, demonstrating significant improvements in patient outcomes through value-based care (VBC) arrangements. The report shows that Medicare Advantage patients under VBC had 32.1% fewer inpatient admissions compared to Original Medicare, and experienced 11.6% fewer ER visits and 7.2% fewer admissions than non-VBC arrangements.
Key findings reveal VBC members had 10% more primary care visits in 2023, with a 90/100 satisfaction rate. The model achieved 25.8% savings in medical costs compared to Original Medicare, which Humana reinvests in member benefits. Black patients visited senior-focused primary care 39% more frequently, while low-income beneficiaries had 21% more visits versus Original Medicare. In specialty care, VBC nephrology programs showed 5% fewer unnecessary hospitalizations compared to fee-for-service models.
Humana Inc. (NYSE: HUM) has announced it will release its fourth quarter 2024 (4Q24) financial results on Tuesday, February 11, 2025, at 6:30 a.m. Eastern time. The company will hold a live Q&A session at 9:00 a.m. Eastern time to discuss quarterly results and 2025 earnings guidance.
Participants can join via telephone by pre-registering through the provided link or access the webcast through Humana's Investor Relations page. The company recommends joining 15 minutes before the call starts. The presentation archive will be available approximately two hours after the live webcast.
The earnings release will include non-GAAP financial measures, with reconciliations to GAAP results provided on the company's website.